ODINK DEBRA 4
4 · Anthera Pharmaceuticals Inc · Filed May 21, 2013
Insider Transaction Report
Form 4
ODINK DEBRA
Chief Technology Officer
Transactions
- Award
Stock option (right to buy)
[F1]2013-05-17+1,400,000→ 1,400,000 totalExercise: $0.61Exp: 2023-05-17→ Common Stock (1,400,000 underlying)
Holdings
- 77,322
Common Stock
- 99,937(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]This stock option granted under our 2013 Stock Option and Incentive plan, which was adopted by the Board of Directors on March 25, 2013 and approved by the shareholders on May 16, 2013, vests annually over four years beginning March 25, 2013 (?the Vesting Start Date?). The Stock Option is completely vested on the fourth anniversary of the vesting start date.
Signature
/s/ Debra Odink|2013-05-20